Previous Close | 78.00 |
Open | 79.50 |
Bid | 78.50 x N/A |
Ask | 79.00 x N/A |
Day's Range | 79.50 - 80.00 |
52 Week Range | 46.78 - 83.00 |
Volume | |
Avg. Volume | 3,170 |
Market Cap | 119.278B |
Beta (5Y Monthly) | 0.80 |
PE Ratio (TTM) | 70.72 |
EPS (TTM) | 1.11 |
Earnings Date | Oct 23, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Here is how Boston Scientific (BSX) and Addex Therapeutics Ltd. Sponsored ADR (ADXN) have performed compared to their sector so far this year.
RMD's stellar first-quarter fiscal 2025 results reflect the ongoing momentum and strong execution across all areas of its business.